Posted 2/6/2018 5:32 AM (GMT 0)
Thanks for starting a new thread.
I think the problem is because you're talking to a urologist, rather than a radiation oncologist. It is probably true that every urologist there would start him on Lupron - that's because they are dealing with him as if he were a post-prostatectomy patient (which is what they know about). Any competent radiation oncologist would know that there is no evidence of a biochemical recurrence, let alone a clinical recurrence. PSA after radiation will fluctuate. Bounces are common and expected. A biochemical recurrence would be called if his PSA rose to 2.14 (nadir +2). Even at that point, many biochemical recurrences are not clinical recurrences - just some prostatitis acting up.
The nadir he reached, 0.14 ng/ml, is very good and is prognostic for a full, enduring cure (especially considering he was only intermediate risk). That's your best-guess assumption until real evidence contradicts it. If you like, go to PSA tests every 3 months, but that's really all that's called for. BTW- One does NOT look at PSADT before a recurrence after radiation - it is only a valid metric post-prostatectomy or after clinical failure. Again, his urologist is treating him as if he had had a prostatectomy. Lose that urologist before he does real harm.
He does not need a PET scan and he does not need a biopsy (let alone Lupron shots!). Those are for after a biochemical recurrence when one wants to see if the cancer is still curable with salvage brachytherapy (as it is about half the time).
I am not a doctor, and I would encourage you to talk to a doctor (a radiation oncologist) who actually knows about this sort of thing. Robert Timmermann at UTSW would be a good person to talk to. I'm sorry that ignorant urologist caused you so much unnecessary anguish.